Home › Acute Lung Injury
Acute Lung Injury clinical trials recruiting in the U.S.
13 studies for Acute Lung Injury are recruiting participants at sites across the United States.
Cities with the most studies
- Durham, NC5 studies
- Nashville, TN5 studies
- Cleveland, OH5 studies
- Mountain View, CA5 studies
- Washington, DC5 studies
- New York City, NY5 studies
- Seattle, WA5 studies
- Boston, MA4 studies
- Sarasota, FL4 studies
- Edison, NJ4 studies
- West Jordan, UT4 studies
- Gainesville, FL4 studies
- Sacramento, CA4 studies
- Houston, TX4 studies
- Somerville, MA4 studies
- Charleston, SC4 studies
- Evanston, IL4 studies
- Fort Worth, TX4 studies
- Oklahoma City, OK4 studies
- St. Petersburg, FL4 studies
- Fresno, CA4 studies
- Boise, ID4 studies
- Birmingham, AL4 studies
- Toledo, OH4 studies
- Charlottesville, VA4 studies
- Denver, CO4 studies
- Ann Arbor, MI4 studies
- Peoria, IL4 studies
- Detroit, MI4 studies
- Rochester, MN4 studies
- Long Beach, CA4 studies
- The Bronx, NY4 studies
- Portland, OR4 studies
- Greenburgh, NY4 studies
- Orange, CA4 studies
By state
- Alabama4 studies
- California6 studies
- Colorado4 studies
- District of Columbia4 studies
- Florida4 studies
- Idaho4 studies
- Illinois6 studies
- Massachusetts4 studies
- Michigan4 studies
- Minnesota5 studies
- New Jersey4 studies
- New York5 studies
- North Carolina5 studies
- Ohio5 studies
- Oklahoma4 studies
- Oregon4 studies
- Pennsylvania3 studies
- South Carolina4 studies
- Tennessee5 studies
- Texas4 studies
- Utah5 studies
- Virginia5 studies
- Washington5 studies
Recently updated studies
Observational, Non-interventional Biomarker and Endotyping Study
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07675265Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 23, 2026 · NCT07613099Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Sep 16, 2026 · NCT07449572Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Aug 10, 2026 · NCT06476132JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701682JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06703073JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701656Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT06513949Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.
RecruitingObservational study
Ages 21 to 90 · All sexes · Updated Jun 10, 2026 · NCT07125079Recovery of Physical Function After Critical Illness In Older Adults
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 99 · All sexes · Updated May 28, 2026 · NCT07225257Clinical Decision Support Tool in PARDS Pilot Study
Recruiting
1 Month – 18 Years · All sexes · Updated Apr 14, 2026 · NCT04068012This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06853223From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.